Follow
Markus Rehberg
Markus Rehberg
Sanofi-Aventis Deutschland GmbH
Verified email at mpi-magdeburg.mpg.de
Title
Cited by
Cited by
Year
Simultaneous model discrimination and parameter estimation in dynamic models of cellular systems
M Rodriguez-Fernandez, M Rehberg, A Kremling, JR Banga
BMC systems biology 7, 1-14, 2013
432013
The relation between growth phases, cell volume changes and metabolism of adherent cells during cultivation
M Rehberg, JB Ritter, Y Genzel, D Flockerzi, U Reichl
Journal of biotechnology 164 (4), 489-499, 2013
282013
Changes in intracellular metabolite pools during growth of adherent MDCK cells in two different media
M Rehberg, A Rath, JB Ritter, Y Genzel, U Reichl
Applied microbiology and biotechnology 98, 385-397, 2014
212014
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis
N Biesemann, D Margerie, C Asbrand, M Rehberg, V Savova, I Agueusop, ...
Science Translational Medicine 15 (681), eabq4419, 2023
162023
Glycolysis is governed by growth regime and simple enzyme regulation in adherent MDCK cells
M Rehberg, JB Ritter, U Reichl
PLoS computational biology 10 (10), e1003885, 2014
152014
Identification of a rule to predict response to sarilumab in patients with rheumatoid arthritis using machine learning and clinical trial data
M Rehberg, C Giegerich, A Praestgaard, H van Hoogstraten, ...
Rheumatology and Therapy 8, 1661-1675, 2021
122021
The influence of cell growth and enzyme activity changes on intracellular metabolite dynamics in AGE1. HN. AAT cells
AG Rath, M Rehberg, R Janke, Y Genzel, S Scholz, T Noll, T Rose, ...
Journal of Biotechnology 178, 43-53, 2014
122014
The regulation of glutaminolysis and citric acid cycle activity during mammalian cell cultivation
M Rehberg, M Wetzel, JB Ritter, U Reichl
IFAC Proceedings Volumes 46 (31), 48-53, 2013
82013
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
A Vugler, J O’Connell, MA Nguyen, D Weitz, T Leeuw, E Hickford, ...
Frontiers in Pharmacology 13, 1037983, 2022
62022
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins
S Pech, M Rehberg, R Janke, D Benndorf, Y Genzel, T Muth, A Sickmann, ...
Applied microbiology and biotechnology 105, 1861-1874, 2021
22021
Dynamics in growth and metabolism of adherent MDCK cells unraveled by an integrated modeling approach
M Rehberg
Otto-von-Guericke-Universitšt Magdeburg, 2015
22015
Real-world Sarilumab use and rule testing to predict treatment response in patients with rheumatoid arthritis: findings from the rise registry
JR Curtis, H Yun, L Chen, SS Ford, H van Hoogstraten, S Fiore, K Ford, ...
Rheumatology and Therapy 10 (4), 1055-1072, 2023
12023
Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
JR Curtis, H Yun, L Chen, SS Ford, H van Hoogstraten, S Fiore, K Ford, ...
Rheumatology and Therapy 11 (1), 217, 2024
2024
The Potential of an Oral TNFa Inhibitor with TNFR1 Specificity: Results of a Phase 1b Proof-of-mechanism Trial in Psoriasis
A Fishbein, MA Nguyen, O Chow, T Matos, C Dreis, H Zhang, M Poirel, ...
ARTHRITIS & RHEUMATOLOGY 75, 859-861, 2023
2023
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data (Sep, 10.1007/s40744-021-00361-5†…
M Rehberg, C Giegerich, A Praestgaard, H van Hoogstraten, ...
RHEUMATOLOGY AND THERAPY 8 (4), 1921-1922, 2021
2021
Real World Validation of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis: Analysis from the RISE Registry
H Yun, J Curtis, L Chen, C Clinton, H van Hoogstraten, S Fiore, ...
ARTHRITIS & RHEUMATOLOGY 73, 2568-2570, 2021
2021
EVALUATION OF NOVEL ANTI-TNFA AND IL-6R THERAPIES IN A RHEUMATOID ARTHRITIS QUANTITATIVE SYSTEMS PHARMACOLOGY PLATFORM.
V Hurez, M Weis, R Baillie, M Rehberg, K Beuke, N Biesemann, ...
CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S99-S99, 2019
2019
Dynamics in central carbon metabolism of adherent MDCK cells
M Rehberg, J Ritter, U Reichl
5th Conference on Systems Biology of Mammalian Cells (SBMC), 2014
2014
Quantitative analysis of glycolysis in MDCK cells during cell growth, medium removal and medium addition
M Rehberg, Y Genzel, JB Ritter, U Reichl
23rd ESACT Meeting, 2013
2013
Funktionsweise der Glykolyse von MDCK Zellen bei Zellwachstum, Medium-Entzug und Medium-Zugabe
M Rehberg, Y Genzel, JB Ritter, U Reichl
GVC/DECHEMA Vortrags-und Diskussionstagung Effiziente Verfahren und Anlagen†…, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20